fenofibrate has been researched along with Psoriasis in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, A | 1 |
| Heo, TH | 1 |
| Lutz, V | 1 |
| Lipsker, D | 1 |
2 other studies available for fenofibrate and Psoriasis
| Article | Year |
|---|---|
IL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy.
Topics: Animals; Autophagy; Cytokines; Disease Models, Animal; Fenofibrate; Humans; Inflammation; Interleuki | 2023 |
Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
Topics: Acitretin; Acrodermatitis; Antirheumatic Agents; Drug Administration Schedule; Drug Resistance, Mult | 2012 |